| Stephen R Shaul, MD | |
|
1470 N 16th Ave, Suite D, Yakima, WA 98902-1381 | |
| (509) 574-6000 | |
| (509) 225-2714 |
| Full Name | Stephen R Shaul |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 1470 N 16th Ave, Yakima, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346226339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD00011637 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen R Shaul, MD 3800 Summitview Ave, Yakima, WA 98902-2715 Ph: (509) 248-7849 | Stephen R Shaul, MD 1470 N 16th Ave, Suite D, Yakima, WA 98902-1381 Ph: (509) 574-6000 |
News Archive
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study to be presented at the 28th Annual EAU Congress in Milan.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
Chronic obstructive pulmonary disease is widespread in China with 8.6 percent of the country's adult population - almost 100 million people -suffering from the chronic lung disease, according to a new Tulane University study published in The Lancet.
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
› Verified 4 days ago
Daniel Doornink, Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 602 E Nob Hill Blvd, Yakima, WA 98901 Phone: 509-248-3334 Fax: 509-453-6144 | |
Robert M Williams, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 3909 Creekside Loop, Suite 130, Yakima, WA 98902 Phone: 509-248-6616 Fax: 509-248-4983 | |
Erik Albert Monick, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 406 S 30th Ave, Suite 101, Yakima, WA 98902 Phone: 509-248-7715 | |
George J Hotchko, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3003 Tieton Dr, Suite 320, Yakima, WA 98902 Phone: 509-452-3765 Fax: 509-452-3435 | |
Sajal Kumar, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 315 Holton Ave, Suite 100, Yakima, WA 98902 Phone: 509-248-6292 Fax: 509-248-9134 | |
Dr. Rosa Maria Martinez, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1111 W Spruce St, Yakima, WA 98902 Phone: 509-576-7064 Fax: 509-576-0679 | |
Dr. Siva Krishna Mannem, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 808 N 39th Ave, Yakima, WA 98902 Phone: 509-574-3400 Fax: 509-574-3464 |